Marketing-authorisation holder · United States
Bpi Labs
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABLYSINOL99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 99% (5ML) · Solution | Dehydrated alcohol | United States | Marketed | 2018 |
| CABAZITAXELUnknown | Cabazitaxel unknown | United States | tentative | 2023 |
| SELENIOUS ACID12ug/2ml | 60ug/1ml · Injection | Selenious acid | United States | tentative | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 1 | 2 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.